Feature Channels: Vision

Filters close
Released: 19-Nov-2024 11:25 AM EST
Common Childhood Injuries: When to Seek Medical Attention
Children's Hospital Los Angeles

According to the Centers for Disease Prevention and Control: 45% of playground injuries are considered severe—fractures, dislocations, and concussions. So it’s important for parents and caregivers to be aware of the physical cues that accompany common pediatric injuries.

Released: 18-Nov-2024 7:45 AM EST
Emmecell Announces Positive Topline Results from Randomized, Double-masked Trial of Groundbreaking Non-surgical Cell Therapy for Corneal Edema
Emmecell

Emmecell, a clinical-stage biotechnology company revolutionizing cell-based therapies for serious eye diseases, today announced exciting topline results from its U.S. multi-center Phase 1 extension study evaluating EO2002, a non-surgical cell therapy for corneal edema. The randomized, double-masked trial demonstrated significant improvements in vision and corneal health, alongside a strong safety profile.

Newswise: Research Concentrates on Genes That Cause Tumors in the Meibomian Gland
Released: 14-Nov-2024 1:30 PM EST
Research Concentrates on Genes That Cause Tumors in the Meibomian Gland
Tufts University

Tufts University researcher dedicated to finding treatments for cancer by researching tumors that develop in Meibomian glands, the specialized oil-secreting glands of the eyelid.

Newswise: jbt_0420edit.jpg
Released: 7-Nov-2024 12:00 PM EST
Retina Specialists at Lurie Children’s Perform Illinois’ First Gene Therapy Eye Surgery with LUXTURNA®
Ann and Robert H. Lurie Children's Hospital of Chicago

The Division of Ophthalmology at Ann & Robert H. Lurie Children’s Hospital of Chicago recently became an Ocular Gene Therapy Treatment Center for LUXTURNA® (voretigene neparvovec-rzl), the first gene therapy approved in the U.S. to treat children and adult patients with a form of vision loss that can result in blindness.

Newswise: Scientists Determine Why Some Patients Don’t Respond Well to Wet Macular Degeneration Treatment, Show How New Experimental Drug Can Bridge Gap
Released: 6-Nov-2024 9:00 AM EST
Scientists Determine Why Some Patients Don’t Respond Well to Wet Macular Degeneration Treatment, Show How New Experimental Drug Can Bridge Gap
Johns Hopkins Medicine

A new study from researchers at Wilmer Eye Institute, Johns Hopkins Medicine explains not only why some patients with wet age-related macular degeneration (or “wet” AMD) fail to have vision improvement with treatment, but also how an experimental drug could be used with existing wet AMD treatments to save vision.

Released: 1-Nov-2024 7:45 AM EDT
Don’t Let Diabetes Dim Your Vision
American Society of Retina Specialists

During November’s Diabetic Eye Disease Awareness Month, the American Society of Retina Specialists encourages people with diabetes, their friends, and loved ones to learn more about diabetic retinopathy and diabetic macular edema and prioritize their eye health to protect and preserve vision.

Newswise: The ‘Eyes’ Have It: Reasons You Should Avoid Color-Changing Eye Drops
Released: 31-Oct-2024 3:15 PM EDT
The ‘Eyes’ Have It: Reasons You Should Avoid Color-Changing Eye Drops
UT Southwestern Medical Center

Fads tend to change in the blink of an eye. This year, some people are being drawn to an eye-catching social media trend of using eye drops that promise to lighten or darken your eye color. The reality is that over-the-counter eye drops cannot change your eye color.

Newswise: picture.jpg
Released: 28-Oct-2024 11:25 AM EDT
Rensselaer Researcher Seeks New Treatment For Blindness-Causing Diseases
Rensselaer Polytechnic Institute (RPI)

Rensselaer Polytechnic Institute’s Christopher Cioffi, Ph.D., Thomas and Constance D'Ambra Professor in Organic Chemistry, has been collaborating with Konstantin Petrukhin, Ph.D., Professor of Ophthalmic Science at Columbia University, to develop compounds to treat dry age-related macular degeneration (AMD) and Stargardt disease — both blindness-causing diseases. The team’s work has led to the discovery of an advanced preclinical candidate. Now, Cioffi and Petrukhin have received a $6.4 million grant over five years from the National Institutes of Health’s National Eye Institute to conduct drug development work and investigational new drug (IND)-enabling toxicology studies.

Newswise: 1920_stem-cells-cedars-sinai.jpg?10000
Released: 24-Oct-2024 11:05 AM EDT
Cell and Gene Therapies Symposium Open to Public
Cedars-Sinai

Clinicians, researchers and the public are invited to learn about stem cell and gene therapies being developed throughout California at the 7th Annual Alpha Clinics Network Symposium, hosted by Cedars-Sinai on Oct. 25.

Released: 22-Oct-2024 12:00 PM EDT
A First Cohort of Graduates From Haiti's School of Optometry
Universite de Montreal

Through an initiative led by UdeM, a first cohort of students is graduating from the State University of Haiti’s School of Optometry. It's a story of perseverance in the face of adversity.

Newswise: Promising New Drug May Be the First to Protect Vision in People With Dry AMD
Released: 21-Oct-2024 10:30 AM EDT
Promising New Drug May Be the First to Protect Vision in People With Dry AMD
American Academy of Ophthalmology (AAO)

Study shows investigational treatment reduced vision loss and protected key structures in the eye essential for vision.

Newswise: New Gene Therapy for Retinitis Pigmentosa Shows Promise
Released: 20-Oct-2024 4:00 PM EDT
New Gene Therapy for Retinitis Pigmentosa Shows Promise
American Academy of Ophthalmology (AAO)

New research suggests that a new kind of gene therapy can improve vision in people who have lost nearly all sight to retinitis pigmentosa.

Newswise: 3D Printed Eyeglasses Help Save Children’s Sight in Remote, Underserved Communities
Released: 20-Oct-2024 3:10 PM EDT
3D Printed Eyeglasses Help Save Children’s Sight in Remote, Underserved Communities
American Academy of Ophthalmology (AAO)

New study shows customized eyeglasses successfully addressed children’s complex eye needs.

Released: 20-Oct-2024 10:45 AM EDT
More Evidence to Support Shift in Standard Glaucoma Care
American Academy of Ophthalmology (AAO)

Six-year study results show laser treatment can preserve vision better than daily eye drops in glaucoma patients.

Newswise: New Study Suggests Aggressive Treatment for Children with Severe Eye Allergies to Avoid Long-term Complications
Released: 20-Oct-2024 9:15 AM EDT
New Study Suggests Aggressive Treatment for Children with Severe Eye Allergies to Avoid Long-term Complications
American Academy of Ophthalmology (AAO)

Research shows people who develop allergies as children with it persisting into adulthood tend to experience more eye complications.

18-Oct-2024 3:10 PM EDT
Long-Term Antiviral Use is Key to Ocular Shingles Treatment
Perelman School of Medicine at the University of Pennsylvania

Year-long use of a typical antiviral treatment for shingles was particularly impactful in reducing complications when the condition eventually affected the eye

Newswise: Considering Cataract Surgery? It Could Save Your Life
Released: 19-Oct-2024 9:15 AM EDT
Considering Cataract Surgery? It Could Save Your Life
American Academy of Ophthalmology (AAO)

New study finds untreated cataracts linked to higher risk of fractures and dangerous brain bleeds due to falls.

Newswise: American Academy of Ophthalmology Announces New International Member Dues
Released: 18-Oct-2024 2:05 PM EDT
American Academy of Ophthalmology Announces New International Member Dues
American Academy of Ophthalmology (AAO)

American Academy of Ophthalmology announces new international member dues.



close
2.28581